Stockscreener 앱 받기
9.87
0.10%
0.010
시간 외 거래:
9.87
전일 마감가:
$9.86
열려 있는:
$9.89
하루 거래량:
1,852
Relative Volume:
0.09
시가총액:
$231.33M
수익:
-
순이익/손실:
$3.55M
주가수익비율:
129.36
EPS:
0.0763
순현금흐름:
$-1.47M
1주 성능:
+0.00%
1개월 성능:
-8.61%
6개월 성능:
-8.61%
1년 성능:
-8.61%
1일 변동 폭
$9.87
$9.90
1주일 범위
$9.86
$9.90
52주 변동 폭
$9.84
$9.99
Twelve Seas Investment Company Iii Stock (TWLV) Company Profile
TWLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWLV
Twelve Seas Investment Company Iii
|
9.87 | 231.09M | 0 | 3.55M | -1.47M | 0.0763 |
|
LION
Lionsgate Studios Corp
|
9.44 | 2.75B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
7.60 | 2.63B | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
13.50 | 804.69M | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.97 | 653.13M | 0 | 0 | 0 | 0.00 |
|
CEPF
Cantor Equity Partners Iv Inc
|
10.47 | 597.79M | 0 | 0 | 0 | 0.00 |
Twelve Seas Investment Company Iii 주식(TWLV)의 최신 뉴스
450,000 Units of Twelve Seas Investment Company III are subject to a Lock-Up Agreement Ending on 11-JAN-2026. - marketscreener.com
Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026 - The Manila Times
Twelve Seas Investment Co III Announces Separate Trading of Shares and Rights - TradingView — Track All Markets
Nasdaq stock bundle splits so traders can buy its pieces alone - Stock Titan
SAMstream Launches AI Platform to Help Organizations of All Sizes Find and Bid on Government Contracts - The Manila Times
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution - The Manila Times
Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference - The Manila Times
Bitfarms to Present at Needham Growth Conference in NYC - The Manila Times
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results - The Manila Times
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference - The Manila Times
iMDx Announces 'JPM Week” and 'BTIG Snowbird” Conference Participation - The Manila Times
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis - The Manila Times
Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference - The Manila Times
Ethan Allen Announces Release Date for its Fiscal 2026 Second Quarter Results - The Manila Times
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation - The Manila Times
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes - The Manila Times
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors - The Manila Times
Abivax Provides 2026 Corporate Outlook - The Manila Times
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2025 Conference Call for February 24, 2026 - The Manila Times
Diamondback Energy, Inc. Schedules Fourth Quarter 2025 Conference Call for February 24, 2026 - The Manila Times
Genelux Corporation Announces Proposed Public Offering of Common Stock - The Manila Times
Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq - The Manila Times
Crane Harbor Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 12, 2026 - The Manila Times
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP - The Manila Times
Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026 - The Manila Times
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Bahamas.com Wins Caribbean’s Best Tourism Authority Website 2025 at World Travel Tech Awards - The Manila Times
Daily News - FinancialContent
Twelve Seas Investment Co III completes $172.5 million IPO and private placement By Investing.com - Investing.com
Twelve Seas Investment Co III Completes IPO and Private Placement - TradingView — Track All Markets
Free cash flow per share of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Return on equity % of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Earnings and Revenue – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt - TradingView — Track All Markets
Discontinued operations of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Balance Sheet – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Income Statement – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Cash Flow – BOATS:TWLVU - TradingView — Track All Markets
Enterprise value of Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Statistics – BOATS:TWLVU - TradingView — Track All Markets
Twelve Seas Investment Company III Units Cons of 1 Shs -A- + 1/10 Rt Financial Statements – BOATS:TWLVU - TradingView — Track All Markets
TWLVR Price History for Twelve Seas Investment Company Rights Stock - Barchart.com
Twelve Seas Investment Company Iii (TWLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.00%
자본화:
|
볼륨(24시간):